17/10/2023 - 12:53

Radiopharm trials to lift pancreatic cancer hopes

17/10/2023 - 12:53

Bookmark

Upgrade your subscription to use this feature.

Pancreatic cancer patients have been delivered fresh hope following the United States Food and Drug Administration’s decision to clear the way for Radiopharm Theranostics to run clinical trials to address an area of “unmet need”. The imaging trials are designed to detect lesions in patients with pancreatic ductal adenocarcinoma and the first patient is expected to receive dosage by the end of this month.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options